Viewing Study NCT04234061


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-26 @ 9:37 PM
Study NCT ID: NCT04234061
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-07
First Post: 2020-01-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module